Milestone Pharmaceuticals Inc
(MIST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | ||
| Net Income | -4,181 | -8,086 |
| Depreciation Amortization | 2 | 8 |
| Other Working Capital | -669 | -164 |
| Other Operating Activity | 125 | 190 |
| Operating Cash Flow | $-4,723 | $-8,052 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | 7,001 | N/A |
| PPE Investments | -5 | -36 |
| Other Investing Activity | 0 | -15,987 |
| Investing Cash Flow | $6,996 | $-16,023 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 30 | N/A |
| Other Financing Activity | 0 | 30,722 |
| Financing Cash Flow | $30 | $30,722 |
| Beginning Cash Position | 10,880 | 4,233 |
| End Cash Position | 13,183 | 10,880 |
| Net Cash Flow | $2,303 | $6,647 |
| Free Cash Flow | ||
| Operating Cash Flow | -4,723 | -8,052 |
| Capital Expenditure | -5 | N/A |
| Free Cash Flow | -4,728 | -8,052 |